P
Protara Therapeutics, Inc. (TARA)
NGM – Real vaqt narxi. Valyuta: USD
5.15
-0.12 (-2.28%)
Yopilishda: May 12, 2026, 4:00 PM EDT
5.29
+0.14 (2.80%)
Bozor oldidan: May 13, 2026, 9:14 AM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
Find any stock by ticker or company name
NGM – Real vaqt narxi. Valyuta: USD
5.15
-0.12 (-2.28%)
Yopilishda: May 12, 2026, 4:00 PM EDT
5.29
+0.14 (2.80%)
Bozor oldidan: May 13, 2026, 9:14 AM EDT
Protara Therapeutics, Inc., klinik bosqichdagi biofarmatsevtika kompaniyasi, saraton va kamyob kasalliklarni davolash uchun transformatsion terapiyalarni rivojlantirish bilan shug'ullanadi. Kompaniyaning asosiy dasturi TARA-002 hisoblanadi, bu tadqiqot ostidagi hujayra terapiyasi bo'lib, mushaklarga invaziv bo'lmagan siydik pufagi saratoni va limfatik malformatsiyalarni davolash uchun II bosqich klinik sinovlarida. Kompaniya, shuningdek, parenteral ovqatlanish va suyuqliklar oladigan bemorlar uchun tadqiqot ostidagi fosfolipid substratni almashtirish terapiyasi bo'lgan venadagi xolin xloridini ishlab chiqmoqda. Kompaniyaning shtab-kvartirasi Nyu-York, Nyu-Yorkda joylashgan.
| Ism | Lavozim |
|---|---|
| Dr. Jacqueline Zummo M.B.A., M.P.H., Ph.D. | Co-Founder, Chief R&D Officer |
| Dr. Leonardo Viana Nicacio M.D. | Chief Medical Officer |
| Dr. Neal D. Shore F.A.C.S., M.D. | Medical Director of START Carolinas/ Carolina Urologic Research Center |
| Dr. Shane Williams Ph.D. | Chief People Officer |
| Mr. Jesse Shefferman | Co-founder, CEO, President & Director |
| Mr. Patrick Fabbio M.B.A. | Chief Financial Officer |
| Mr. William Conkling | Chief Commercial Officer |
| Ms. Hannah Fry | VP, Principal Accounting Officer & Controller |
| Ms. Justine O'Malley | Senior Vice President of Investor Relations & Corporate Affairs |
| Ms. Mary J. Grendell J.D. | General Counsel & Corporate Secretary |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-04-28 | DEFA14A | ea0286228-05.htm |
| 2026-04-17 | PRE 14A | ea0286228-01.htm |
| 2026-03-30 | 8-K | ea0283949-8k_protara.htm |
| 2026-03-10 | 8-K | ea0280404-8k_protara.htm |
| 2026-02-24 | 8-K | ea0277972-8k_protara.htm |
| 2025-12-15 | 8-K | ea0269478-8k_protara.htm |
| 2025-12-08 | 8-K | ea0268756-8k_protara.htm |
| 2025-12-03 | 8-K | ea0268248-8k_protara.htm |
| 2025-11-19 | 8-K | ea0266384-8k_protara.htm |
| 2025-11-10 | 10-Q | ea0262733-10q_protara.htm |